论文部分内容阅读
目的观察舒利迭干粉剂对慢性稳定期慢性阻塞性肺疾病(COPD)的疗效。方法将56例处于慢性缓解期的COPD患者,随即分成实验组和对照组。对照组给予常规治疗,实验组在此基础上给予吸入舒利迭(50/250)。记录治疗前后的患者症状缓解情况,肺功能和血气分析指标。结果实验组的总有效率显著高于对照组,两组疗效比较差异有统计学意义(P<0.05)。结论应用舒利迭(50/250)治疗慢性缓解期COPD,能显著改善肺功能,动脉血气指标,患者依从性好,副反应少。
Objective To observe the curative effect of seretide dry powder on chronic stable chronic obstructive pulmonary disease (COPD). Methods Fifty-six COPD patients with chronic remission were randomly divided into experimental group and control group. The control group was given routine treatment, and the experimental group was given inhaled seretide (50/250) on this basis. Records of patients before and after treatment to alleviate the symptoms, lung function and blood gas analysis indicators. Results The total effective rate of the experimental group was significantly higher than that of the control group, the difference between the two groups was statistically significant (P <0.05). Conclusion The application of seretide (50/250) in the treatment of chronic remission COPD can significantly improve pulmonary function and arterial blood gas indexes. The patients have good compliance and few side effects.